Tata Memorial To Build India’s Largest Bone Marrow Centre

09 Oct 2025 CW Team

The 11-storey facility, to be named the NSE Multispecialty Hospital Block and Bone Marrow Transplant Cancer Hospital, will be built by Larsen & Toubro (L&T). A bhoomipujan ceremony was held on Sunday to mark the project’s commencement. Once construction is completed, the building will be handed over to ACTREC.

Dr Pankaj Chaturvedi, Director of ACTREC, said the new 60-bed facility would significantly expand the centre’s capabilities. “At present, we have a five-bed BMT centre. Once the new building is ready, we will be able to perform 600 bone marrow transplants each year,” he said.

Expected to be operational by July 2027, the centre will also handle about 130,000 outpatient consultations annually, vastly improving access to specialised cancer care.

ACTREC currently performs over 100 bone marrow transplants every year and treats more than 300 patients daily. It also pioneered India’s first indigenous CAR-T cell therapy for blood cancer in 2021.

Dr Chaturvedi added that the upcoming facility would offer the most affordable bone marrow transplants in the country. While the procedure can cost over Rs 40 lakh (Rs 4 million) in private hospitals and upwards of Rs 10 lakh (Rs 1 million) even in public institutions, the Tata Memorial Centre helps families secure financial assistance through donations and charity support.

The groundbreaking ceremony was attended by key dignitaries, including Ashishkumar Chauhan, Managing Director and Chief Executive Officer of NSE; Dr Sudeep Gupta, Director, Tata Memorial Centre; Dr Pankaj Chaturvedi, Director, ACTREC; and Dr Navin Khattry, Deputy Director, ACTREC and Head of the BMT Programme.

According to an NSE release, “This collaboration represents a major step toward bridging the gap in affordable, high-quality cancer care across India, bringing critical treatment access to thousands in need.”

The Tata Memorial Centre’s Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Kharghar will soon house India’s largest bone marrow transplant (BMT) facility, with funding support of Rs 3.8 billion from the National Stock Exchange (NSE) through its Corporate Social Responsibility (CSR) initiative.The 11-storey facility, to be named the NSE Multispecialty Hospital Block and Bone Marrow Transplant Cancer Hospital, will be built by Larsen & Toubro (L&T). A bhoomipujan ceremony was held on Sunday to mark the project’s commencement. Once construction is completed, the building will be handed over to ACTREC.Dr Pankaj Chaturvedi, Director of ACTREC, said the new 60-bed facility would significantly expand the centre’s capabilities. “At present, we have a five-bed BMT centre. Once the new building is ready, we will be able to perform 600 bone marrow transplants each year,” he said.Expected to be operational by July 2027, the centre will also handle about 130,000 outpatient consultations annually, vastly improving access to specialised cancer care.ACTREC currently performs over 100 bone marrow transplants every year and treats more than 300 patients daily. It also pioneered India’s first indigenous CAR-T cell therapy for blood cancer in 2021.Dr Chaturvedi added that the upcoming facility would offer the most affordable bone marrow transplants in the country. While the procedure can cost over Rs 40 lakh (Rs 4 million) in private hospitals and upwards of Rs 10 lakh (Rs 1 million) even in public institutions, the Tata Memorial Centre helps families secure financial assistance through donations and charity support.The groundbreaking ceremony was attended by key dignitaries, including Ashishkumar Chauhan, Managing Director and Chief Executive Officer of NSE; Dr Sudeep Gupta, Director, Tata Memorial Centre; Dr Pankaj Chaturvedi, Director, ACTREC; and Dr Navin Khattry, Deputy Director, ACTREC and Head of the BMT Programme.According to an NSE release, “This collaboration represents a major step toward bridging the gap in affordable, high-quality cancer care across India, bringing critical treatment access to thousands in need.”

Infrastructure Transport

06 Feb 2026

Lucknow Metro East-West Corridor Consultancy Contract Awarded

The Uttar Pradesh Metro Rail Corporation has awarded the first construction-related consultancy contract for the Lucknow Metro East West Corridor to a joint venture of AYESA Ingenieria Arquitectura SAU and AYESA India Pvt Ltd. The firm was declared the lowest bidder for the Detailed Design Consultant contract for Lucknow Metro Line-2 under Phase 1B and the contract was recommended following the financial bid. The contract is valued at Rs 159.0 million (mn), covering design services for the corridor. Lucknow Metro Line-2 envisages the construction of an 11.165 kilometre corridor connecting Cha..

Infrastructure Urban

06 Feb 2026

Div Com Kashmir Urges Fast Tracking Of Jhelum Water Transport Project

The Divisional Commissioner of Kashmir has called for the fast-tracking of the Jhelum water transport project, urging district administrations and relevant agencies to accelerate planning and clearances. In a meeting convened at the divisional headquarters, the commissioner instructed officials from irrigation, public health engineering and municipal departments to prioritise the project and coordinate survey and design work. The directive emphasised removal of administrative bottlenecks and close monitoring to ensure timely mobilisation of resources and contractors. Officials were told to in..

Infrastructure Urban

06 Feb 2026

Interarch Reports Strong Q3 And Nine Month Results

Interarch Building Solutions Limited reported unaudited results for the third quarter and nine months ended 31 December 2025, recording strong revenue growth driven by execution and a robust order book. Net revenue for the third quarter rose by 43.7 per cent to Rs 5.225 billion (bn), compared with Rs 3.636 bn a year earlier, reflecting heightened demand in pre-engineered building projects. The company’s total order book as at 31 January 2026 stood at Rs 16.85 bn, supporting near-term visibility. EBITDA excluding other income for the quarter increased by 43.2 per cent to Rs 503 million (mn),..